 |
Previous Article | Next Article 
Volume 16, Number 11,
Issue of June 1, 1996
pp. 3601-3619
Copyright ©1996 Society for Neuroscience
Tau Is Enriched on Dynamic Microtubules in the Distal Region of
Growing Axons
Mark M. Black1,
Theresa Slaughter1,
Simon Moshiach1,
Maria Obrocka2, and
Itzhak Fischer2
1 Department of Anatomy and Cell Biology, Temple
University School of Medicine, Philadelphia, Pennsylvania 19140, and
2 Department of Neurobiology and Anatomy, Medical College
of Pennsylvania and Hahnemann University, Philadelphia, Pennsylvania
19129
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
FOOTNOTES
REFERENCES
ABSTRACT
It is widely held that tau determines the stability of microtubules
in growing axons, although direct evidence supporting this hypothesis
is lacking. Previous studies have shown that the microtubule polymer in
the distal axon and growth cone is the most dynamic of growing axons;
it turns over more rapidly and is more sensitive to microtubule
depolymerizing drugs than the polymer situated proximally. We reasoned
that if the stability of axonal microtubules is directly related to
their content of tau, then the polymer in the distal axon should have
less tau than the polymer in the proximal axon. We tested this
proposition by measuring the relative tau content of microtubules along
growing axons of cultured sympathetic neurons immunostained for tau and
tubulin. Our results show that the tau content of microtubules varies
along the axon, but in the opposite way predicted. Specifically, the
relative tau content of microtubules increases progressively along the
axon to reach a peak near the growth cone that is severalfold greater
than that observed proximally. Thus, tau is most enriched on the most
dynamic polymer of the axon. We also show that the gradient in tau
content of microtubules does not generate corresponding gradients in
the extent of tubulin assembly or in the sensitivity of axonal
microtubules to nocodazole. On the basis of these findings, we propose
that tau in growing axons has functions other than promoting
microtubule assembly and stability and that key sites for these
functions are the distal axon and growth cone.
Key words:
microtubule-associated proteins;
cytoskeleton;
axon
growth;
quantitative digital image analysis;
cultured sympathetic
neurons
INTRODUCTION
Tau is a developmentally regulated
microtubule-associated protein (MAP). Tau is encoded by a single gene,
but because of alternative splicing and phosphorylation, it shows
multiple isoforms (for review, see Wiche et al., 1991 ). During neuronal
differentiation tau undergoes a transition from immature to mature
forms that involves a dramatic increase in the number of isoforms (for
review, see Schoenfeld and Obar, 1994 ). A role for tau in axon growth
was initially suggested by studies that demonstrated a temporal
correlation between the expression of tau, microtubule (MT) assembly,
and axon extension (Drubin et al., 1985 ). More recently, studies that
have altered tau expression either upward or downward have reinforced
the view that tau participates in axon growth. Specifically,
suppressing tau expression can prevent axon growth, whereas
overexpressing tau can promote the elaboration of neurite-like
processes that contain arrays of parallel MTs in cells that normally do
not elaborate such processes (for review, see Hirokawa, 1994 ).
Although the importance of tau in axon growth is well established, its
specific functions are unknown. Because tau binds MTs, its functions
presumably involve, at least in part, binding to MTs. On the basis of
its ability to promote MT assembly and stability in vitro,
tau has been proposed to promote MT assembly and stabilization in
growing axons (Brandt and Lee, 1993 ; see also references therein).
However, most studies on tau function have used tau purified from adult
brain. This tau is very different from tau in developing neurons, and
some of the differences influence the ability of tau to bind and
stabilize MTs. For example, the MT binding domain of tau in developing
neurons consists of three MT binding repeats whereas adult tau has four
repeats. Experiments using recombinant tau have shown that three-repeat
tau is a relatively weak stabilizer of MTs whereas four-repeat tau is a
potent stabilizer (Goode and Feinstein, 1994 ; Trinczek et al., 1995 ).
Furthermore, tau in developing neurons is subject to phosphorylation
events that substantially reduce its assembly promoting activity
(Bramblett et al., 1993 ). These findings question whether tau functions
to promote MT assembly or stability in developing axons.
Several recent observations have shown that the stability of MTs varies
along the length of growing axons. Specifically, the polymer located
distally near the growth cone turns over more rapidly and is more
sensitive to treatments with MT depolymerizing drugs than the polymer
situated elsewhere in the axon (Lim et al., 1989 ; Brown et al., 1992 ;
Ahmad et al., 1993 ; Baas et al., 1993 ; Edson et al., 1993 ; Li and
Black, 1996 ). This naturally occurring spatial variation in the
stability properties of MTs in growing axons must reflect a
corresponding variation in the factors that promote MT stability. If
tau is a significant MT stabilizer in growing axons, then the polymer
in the proximal axon will contain more tau than the polymer in the
distal axon. We have used quantitative immunofluorescence procedures to
test this prediction. Our results show that the tau content of MTs
varies along the axon, but in a manner that is opposite to that
expected on the basis of the hypothesis that tau promotes MT
stability.
MATERIALS AND METHODS
Materials. Culture media were obtained from Gibco
(Grand Island, NY). Supplements for culture media were obtained from
either Gibco or Sigma (St. Louis, MO), except for NGF, which was
purified from mouse salivary glands according to Mobley et al. (1976).
Nocodazole was obtained from Aldrich (Milwaukee, WI), and other
reagents were obtained from Sigma unless otherwise indicated.
Cell culture. All experiments reported here used rat
sympathetic neurons dissociated from the SCGs of newborn pups as
described by Black and Kurdyla (1983) . For immunostaining analyses,
neurons were plated at relatively low density onto glass coverslips
coated with polylysine and laminin (obtained from Collaborative
Biomedical Products, Bedford, MA) as described previously (Brown et
al., 1992 ; Black et al., 1994 ). All of the studies presented here were
performed on cultures that varied between 17 and 25 hr in age from the
time of plating. By this time, most of the neurons had extended one or
more axons but no dendrites; typical axons ranged in length from ~300
to ~700 µm. For biochemical analyses, neurons were plated onto
plastic dishes coated with polylysine and laminin as described above
except that the medium was supplemented with 3% FCS (HyClone, Logan,
UT). Cells were plated at a density of 2 ganglia per dish and used the
following day. At this time, the cultures consisted principally of
neurons that had elaborated relatively long, branched axons.
Preparation of polyclonal antibodies against tau. Two
polyclonal antibodies against tau were prepared against fusion protein
constructs containing discrete regions near the N terminus or C
terminus of the protein (see Fig. 1A). Two
cDNA clones encoding the N- and C-terminal ends of tau were prepared by
RT-PCR using two sets of primers designed on the basis of the sequence
of the high molecular weight isoform of rat tau (Goedert et al., 1992 ),
with the addition of restriction sites (BamHI and
EcoRI) for directional cloning. The 5TA and 5TB primers
(sense and antisense sequences from the 5 end of the tau cDNA) spanned
the N terminus at aa 2-113, whereas the 3TA and 3TB primers (sense and
antisense sequences from the 3 end of the tau cDNA) spanned the C
terminus at aa 616-686. RNA was prepared from adult rat brain
(Chomcynski and Sacchi, 1987 ), and the corresponding cDNA was reversed
transcribed using either oligo(dT) or random hexamer primers. The cDNA
and the two sets of primers were used for PCR amplification to obtain
the corresponding products of tau. The N-terminal fragment of tau (336 bp encoding 112 aa) was designated tau-5 , whereas the C-terminal
fragment (210 bp encoding 70 aa) was designated tau-3 . The PCR
products were digested with BamHI and EcoRI and
subcloned into the pGEX-2T expression vector (Pharmacia, Piscataway,
NJ). This vector has the glutathione S-transferase (GST) gene fusion
system that can be induced by IPTG. The GST-tau fusion proteins
containing the recombinant fragments of tau protein were expressed in
Escherichia coli and then affinity-purified using
glutathione-Sepharose. Rabbits were injected with 200-500 µg of the
recombinant tau fusion protein using complete Freund's adjuvant
followed by three booster injections of 100 µg of protein in
incomplete Freund's adjuvant. Specificity of the resulting antibodies
for tau was confirmed by immunoblotting against extracts from brain
(see Fig. 1).
Fig. 1.
Characterization of polyclonal antibodies against
tau. A shows a schematic of the tau cDNA, the primers used
for RT-PCR, and the constructs used to prepare fusion proteins for use
in antibody production. The sequences of the primers, from 5 to 3 ,
are as follows: primer 5TA, CTC GGA TCC GCT GAA CCC CGC CAG GAG TTT;
primer 5TB, CTC GAA TTC CTT GAG TCA CAT GCC CAG CAG C; primer 3TA, CTC
GGA TTC GAA ACC CAC AAG CTG ACC; primer 3TB, CTC GAA TTC ACA AAC CCT
GCT TGG CCA A. B-D show portions of blots of soluble
extracts of immature rat brain, adult rat brain, and cultured
sympathetic neurons (lanes 1, 2, and 3,
respectively) probed by the tau-3 polyclonal (B), tau1 + tau49 monoclonal (C), and tau-5 polyclonal (D)
antibodies against tau; ~10-30 µg of each type of type was applied
to the gels. The polyclonal and monoclonal antibodies recognize the
same set of bands in each type of sample.
[View Larger Version of this Image (46K GIF file)]
Fixation and extraction of neurons. Cultured neurons were
processed for immunofluorescence localization of tubulin and tau
according to one of the following four procedures. For procedure 1, cells were rinsed once with PBS, once with PHEM (60 mM PIPES, 25 mM HEPES, 10 mM EGTA, 2 mM
MgCl2, pH 6.9; Schliwa and van Blerkom, 1981 ),
and then simultaneously fixed and extracted by incubation with PHEM
containing 0.2% (w/v) saponin (Sigma), 4.0% paraformaldehyde (EM
Sciences, Gibbstown, NJ), and 0.1% glutaraldehyde (Polysciences,
Warrington, PA) for 10 min. After fixation, the cells were rinsed with
PBS and then permeabilized by incubation with 0.1% Triton X-100 (in
PBS) for 2 min. For procedure 2, cells were fixed without extraction by
incubation in 4.0% paraformaldehyde and 0.1% glutaraldehyde in PBS.
After fixation, the cells were rinsed with PBS and then permeabilized
by incubation with 0.1% Triton X-100 (in PBS) for 2 min. Procedure 3 was the combined fixation and extraction procedure described by Lee and
Rook (1992) . Cells were rinsed once with PBS and once with PEM (80 mM PIPES, 5 mM EGTA, 1 mM MgCl2, pH 6.8) and then
incubated with PEM containing 0.5% (w/v) NP-40 and 0.3%
glutaraldehyde for 10 min. After fixation, the cells were rinsed with
PBS and then further permeabilized by incubation with 0.5% Triton
X-100 in PBS for 10 min. Procedure 4 involved fixation without
extraction in PEM containing 0.3% glutaraldehyde for 10 min. After
fixation, the cells were rinsed with PBS and then permeabilized by
incubation with 0.5% Triton X-100 (in PBS) for 15 min.
For some experiments, cells were extracted before fixation using
conditions that stabilize existing MTs and remove unassembled tubulin.
Neurons were rinsed once with PBS, once with PHEM or PEM, and then
extracted at room temperature for 2 min in PHEM or PEM containing 0.2%
saponin and 10 µM taxol (a gift from Ms.
Nancita Lomax of the National Cancer Institute); variations from this
basic protocol are described in Results. Taxol was made as a 10 mM stock solution in DMSO, and appropriate
volumes were added to the extraction buffer immediately before use. The
extraction solution also contained a mixture of protease inhibitors
(0.5 mM PMSF, 0.2 trypsin inhibitory units/ml
aprotinin, and 10 µg/ml each leupeptin, chymostatin, and antipain).
After extraction, the cells were fixed using procedure 1, 3, or 4 as
described above.
After fixation and permeabilization, the dishes were rinsed with PBS,
treated with sodium borohydride (10 mg/ml in PBS for 7 min), incubated
with 0.1 M glycine in PBS for 20 min, rinsed with
PBS again, and then incubated with blocking solution for 30 min.
Blocking solution consisted of either 4% normal donkey serum in PBS or
1% nonfat dry milk + 0.1% Tween-20 in PBS. The cells were then
double-stained to reveal tau and tubulin (see below). All antibodies
were diluted in blocking solution and then clarified before use by
centrifugation at 200,000 × g for 10 min in a Beckman
TL-100 ultracentrifuge (Beckman Instruments, Palo Alto, CA). After
incubation with secondary antibody, cells were rinsed extensively with
PBS and then mounted in 80% (w/v) glycerol in PBS containing 10 mg/ml
n-propyl gallate.
Immunofluorescence procedures. Cells were double-stained for
tubulin and tau using one of the following conditions. Staining
condition 1: cells were incubated first with a mouse monoclonal
anti- -tubulin antibody [purchased from Amersham (Arlington Heights,
IL; Blose et al., 1984 ] for 45 min at 37°C, rinsed twice with
blocking solution, and then incubated with one of the rabbit polyclonal
antibodies against tau (most experiments used the antibody against the
N-terminal region, tau-5 ) for 2 hr at room temperature; the polyclonal
antibodies were typically used at a dilution of 1:1000, although
similar results were obtained with dilutions ranging from 1:200 to
1:3000. After extensive rinsing with PBS and then reblocking, cells
were incubated simultaneously with FITC-conjugated goat anti-mouse
antibody, at a dilution of 1:100, and lissamine-conjugated donkey
anti-rabbit antibody, at a dilution of 1:100. All secondary antibodies
were purchased from Jackson Immunoresearch Laboratories (West Grove,
PA; AffiniPure grade, preadsorbed for minimum cross-reactivity). In
some experiments, cells were double-stained for -tubulin and either
MT-associated protein 2 (MAP2) or MT-associated protein 1b (MAP1b).
These experiments used the same protocol described for staining
condition 1 but used either a polyclonal antibody against MAP1b (Black
et al., 1994 ) or MAP2 (Fischer and Romano-Clarke, 1991 ) in place of the
polyclonal antibody against tau. Staining condition 2: cells were
incubated with a rabbit polyclonal antibody against tau overnight at
4°C, rinsed with blocking solution, and then incubated with the
monoclonal anti- -tubulin antibody for 2 hr at 37°C. After
extensive rinsing with PBS and then reblocking, the cells were
incubated with secondary antibodies as described above. Staining
condition 3: cells were double-stained for tubulin and tau using mouse
monoclonal antibodies against tau and a rabbit polyclonal antibody
against tyrosinated -tubulin (diluted 1:400, generously provided by
Dr. Chloe Bulinski, Columbia University School of Medicine, New York,
NY) (Gundersen et al., 1984). Cells were first incubated with the
anti-tubulin antibody for 45 min at 37°C, rinsed with blocking
solution, and then incubated with a cocktail of mouse monoclonal
antibodies against tau consisting of tau1, tau14, and tau60 for 2 hr at
room temperature (tau14 and tau60 were generously provided by Dr.
Virginia Lee, Department of Pathology, University of Pennsylvania,
Philadelphia, PA; tau1 was generously provided by Dr. Lester Binder,
Northwestern University Medical School, Chicago, IL). After extensive
rinsing and reblocking, the cells were incubated simultaneously with
FITC-conjugated donkey anti-rabbit antibody and lissamine-conjugated
donkey anti-mouse antibody, both diluted 1:100.
For some experiments, the rabbit polyclonal antibody against the
N-terminal region of tau (tau-5 ) was preincubated with boiled MAPs
prepared from brains of newborn rat pups. MTs were assembled from a
high-speed supernate of the brains using taxol, and then the MAPs were
isolated from the MTs using NaCl extraction followed by incubation at
100°C for 5 min (Vallee, 1982 ; Peng et al., 1985 ). For preadsorption
experiments, the polyclonal antibody was incubated with either the MAP
preparation or the NaCl-containing buffer used to extract MAPs from MTs
for 15 min at room temperature, clarified by centrifugation, and then
used for immunostaining as described above.
Image acquisition and analysis. Neurons were observed by
epifluorescence microscopy using a Zeiss Axiovert 135 inverted
microscope (Zeiss, Thornwood, NY), and images were obtained with a
CH250 cooled CCD camera (Photometrics Ltd., Tucson, AZ) equipped with a
Thompson 7883 CCD chip. The details of the imaging system have been
described previously (Brown et al., 1992 ; Black et al., 1994 ; Li and
Black, 1996 ). Images were acquired using the full usable area of the
CCD chip, which measured 382 × 576 pixels, and stored in full 12-bit
format on magneto-optical disks using Pinnacle optical disk drives
(Pinnacle Micro, Irvine, CA). Before capturing a series of images, an
instantaneous readout of the bias voltage offset on the chip was saved
and subsequently subtracted from each exposed image. Dark current
(0.133 ADU/sec) was not significant for the exposure times used in
these studies. The magnification of the CCD images was calibrated using
a stage micrometer. For maximum precision, all measurements of
fluorescence intensity (see below) were performed on the 12-bit images.
For presentation, images were scaled to 8 bits.
To evaluate the overall distribution of tubulin and tau in growing
axons, cells were imaged using a 25×/0.8 N.A. plan neofluar
oil-immersion objective to capture the entire length of the axons in
single images. To examine MT staining for tubulin and tau at higher
resolution, cells were imaged with a 100×/1.3 N.A. plan neofluar
oil-immersion objective. We used the segmented mask procedure to
quantify the intensity of tubulin and tau staining along the length of
individual axons (Brown et al., 1992 ). For these analyses, we selected
axons with relatively simple morphology, having no more than one branch
point. Briefly, the -tubulin image was used to generate a mask of
the axon that extended from the cell body to the tip of the axon. The
mask was divided into consecutive ~6.4-µm-long segments beginning
at the cell body-axon transition and continuing to the axon tip; the
growth cone was contained in the most distal one or two segments. The
segmented mask was then overlaid on the original fluorescent images
depicting the distribution of tau and -tubulin. This allowed us to
define segments in the fluorescent images that corresponded to the
segments in the mask. To correct for background fluorescence in each
image, an average background pixel intensity was calculated for each
segment and then subtracted from each pixel within that segment. Then,
the total fluorescence intensity for the segments in each image was
calculated by summing the corrected intensities of the pixels
comprising each segment. The fluorescence intensity of each segment,
measured as arbitrary analog-to-digital units (ADU), was then plotted
against distance along the axon (see Figs. 6, 11). These procedures
have been incorporated into a single interactive application program
written in the Oncor Imaging programming language. A synopsis of these
procedures is presented in Brown et al. (1992) , and a more detailed
description will be provided on request.
Fig. 6.
Quantitative analyses of the relative amounts of
total tubulin and total tau along the axon. Cells fixed and then
permeabilized (according to procedure 4) were double-stained for
-tubulin and tau according to staining condition 2. Images of the
cells were obtained with the cooled CCD camera and then analyzed using
the segmented mask procedure. Data from two representative neurons are
shown. A and D show computer-generated tracings
of these neurons; scale bar, 56 µm. B and E
show the fluorescence intensity for tubulin and tau plotted against
distance from the cell body. C and F show the
ratio of tau fluorescence-to-tubulin fluorescence plotted against
distance from the cell body. The arrow in A
identifies the axon subjected to quantitative analysis. The
arrows in D-F indicate branch points, while the
arrowheads indicate where two axons cross over each
other.
[View Larger Version of this Image (41K GIF file)]
Fig. 11.
Quantitative analyses of the relative amounts of
assembled tubulin and assembled tau along the axon. Cells processed by
combined fixation and extraction (according to procedure 3) were
double-stained for -tubulin and tau according to staining condition
2. Images of the cells were obtained with the cooled CCD camera and
then analyzed using the segmented mask procedure. Data from two
representative neurons are shown. A and D show
computer-generated tracing of these neurons; scale bar, 56 µm.
B and E show the fluorescence intensity for
tubulin and tau plotted against distance from the cell body.
C and F show the ratio of tau
fluorescence-to-tubulin fluorescence plotted against distance from the
cell body. The arrows in D-F indicate
branch points.
[View Larger Version of this Image (42K GIF file)]
Measurements of axonal volume. Measurements of volume along
the length of axons were based on -tubulin stained images of cells
fixed without extraction (according to procedure 4) and double-stained
for -tubulin and tau. Briefly, the segmented mask procedure, in
addition to measuring fluorescence intensity for each axon segment also
provides a measure of the area of each segment in pixels. Each segment
is approximately rectangular in shape, with a length that is specified
by the user as part of the analysis. We calculated the width of each
segment based on its specified length and measured area, converted the
value for the width from pixels into micrometers, and then, assuming
that the axon is cylindrical in shape, used the width of each segment
as a measure of its diameter to compute segment volume. We chose a
cylindrical model because cross sections of axons of cultured neurons
have a circular contour (Black et al., 1984 ). This model is adequate
for most of the axon, except at branch points and at the growth cone.
The axons that we studied branched minimally along their length, and
the growth cone was contained in the most distal one or two segments of
the axon. We have not corrected our volume determinations for segments
containing branch points or the growth cone for deviations from a
cylindrical shape. The resulting volume measurements were used to
generate plots of volume as a function of position along the axon and
to normalize the fluorescence intensity for -tubulin and tau along
the axon to axon volume (see Results and Fig. 7).
Fig. 7.
Quantitative analyses of the volume densities of
tubulin and tau along the axon. Cells fixed and then permeabilized
(according to procedure 4) were double-stained for -tubulin and tau
according to staining condition 2. Images of the cells were obtained
with the cooled CCD camera and then analyzed using the segmented mask
procedure. For each axon analyzed, we determined the volume (in
µm3), the fluorescence intensity of
-tubulin, and the fluorescence intensity of tau for each axon
segment. To calculate the volume densities of -tubulin and tau for
each axon segment, the fluorescence intensities attributable to
-tubulin and tau for each segment were divided by segment volume.
The resulting segment volumes and volume densities were plotted against
distance from the cell body. Data from two representative neurons are
shown. A and B show the data from one neuron (the
same neuron shown in Fig. 5A-C), whereas C and
D show the results from a different neuron (the same neuron
shown in Fig. 5D-F). A and C show the
volume of each segment plotted against distance from the cell body.
B and D show the volume densities of -tubulin
and tau plotted against distance from the cell body. The
arrows and arrowheads in C and
D are as defined for Figure
5D-F.
[View Larger Version of this Image (36K GIF file)]
Preparation of extracts of cultured neurons for biochemical
analyses. Total tau as well as tau in cytoskeletal and soluble
fractions of cultured neurons were prepared for analysis by
immunoblotting. For total tau, whole-cell SDS extracts were prepared by
scraping cultured neurons into 1% SDS plus a cocktail of protease
inhibitors that included 0.2 trypsin inhibitory units/ml of aprotinin
and 10 µg/ml each leupeptin, chymostatin, and antipain, and 0.5 mM PMSF. The extracts were incubated at 100°C
for 5 min and then clarified by centrifugation in the TL100.2 rotor
(Beckman Instruments) at 75,000 rpm for 15 min at 22°C.
To prepare soluble and cytoskeletal fractions from cultures, cultures
were rinsed once with PBS, once with PHEM or PEM, and then scraped into
PHEM or PEM supplemented with 0.2% Triton X-100 or 0.2% saponin,
respectively, 10 µM taxol, and protease
inhibitors (all buffers were at room temperature). Soluble and
cytoskeletal fractions were obtained by centrifugation of cell extracts
at 75,000 rpm for 10 min at 22°C in the TL100.2 rotor. The soluble
fraction was removed and its protein precipitated by the addition of
~8 volumes of cold methanol. The resulting methanol-precipitated
material was collected by centrifugation, air-dried, dissolved in 1%
SDS, and then incubated at 100°C for 5 min. The cytoskeletal pellet
was rinsed once with PHEM or PEM + 10 µM taxol
and then dissolved directly in 1% SDS, and then incubated at 100°C
for 5 min. The resulting materials were then analyzed by SDS-PAGE and
immunoblotting.
SDS-PAGE and immunoblotting. Protein samples were resolved
in 4-10% SDS-PAGE gels and then transferred onto nitrocellulose
membranes (1000 mA for 3 hr at 4°C). The transfers were then
incubated with primary antibodies followed by HRP-conjugated secondary
antibodies and detection by chemiluminescence using ECL reagents
(Amersham). The antibodies against the recombinant tau fragments
(tau-3 and tau-5 ) were used at 1:100,000, the monoclonal antibodies
against tau (a cocktail consisting of tau1 and tau49) were used at a
dilution of 1:4000 and secondary antibodies at 1:4000. Quantification
of immunoreactivity was performed using the ONE-DSCAN software package
(Scanalytics, Billerica, MA). Immunoblot images obtained on x-ray film
after detection by chemiluminescence were scanned on a Sharp JX330
color image scanner at a resolution of 600 × 600 dpi. The images were
analyzed by calculating the integrated density of each band determined
by fitting the density profile with multiple Gaussian peaks.
RESULTS
The present experiments examine the tau content of MTs in axons
and growth cones of cultured sympathetic neurons, and the effects of
tau on MT stability and the extent of MT assembly in growing axons of
these neurons. In a previous study, we used quantitative
immunofluorescence procedures to evaluate the MAP1b content of MTs
along the length of growing axons (Black et al., 1994 ). These studies
showed that MAP1b bound avidly to MTs all along the axon and that it
was highly enriched on MTs in the distal part of the axon contiguous
with the growth cone. In designing the present experiments, we expected
that the procedures that worked well in our analyses of MAP1b would
also work for tau. However, this was not the case. In fact, the binding
of tau to MTs is very labile to several conditions of fixation and
extraction that preserve MAP1b (and MAP2) interactions with MTs. In the
following sections, we first document the specificity of the tau
polyclonal antibodies used in the present experiments. Then, we present
our results on the sensitivity of tau binding to MTs, followed by our
findings concerning tau localization and tau content of MT in growing
axons. Finally, we show that the variations in the tau content of MTs
that naturally occur in growing neurons do not generate corresponding
variations in MT sensitivity to MT depolymerizing drugs or the extent
of MT assembly.
Characterization of antibody reagents against tau
The present studies used two polyclonal antibodies raised against
distinct regions of the tau molecule. One antibody (tau-5 ) was
directed against the N terminus, and the other (tau-3 ) was directed
against the C terminus of tau (see Materials and Methods). The
specificity of the antibodies was examined by Western blot analyses
with whole-cell extracts prepared from immature and adult rat brain and
cultures of rat sympathetic neurons. In homogenates of immature rat
brain, both antibodies recognized a single band of ~45 kDa, whereas
in extracts of adult rat brain, both antibodies recognized at least six
tau isoforms ranging from 45 to 65 kDa in molecular mass (Fig.
1B,D); no other bands were recognized by either antibody.
The same set of bands was also recognized in preparations of cycled MTs
(data not shown) and by various well characterized monoclonal
antibodies against tau (Fig. 1C). These results indicate
that both tau-5 and tau-3 are highly specific for tau and recognize
all tau isoforms, including high molecular weight tau (see below).
We used the polyclonal antibodies (tau-3 and tau-5 ) as well as a mix
of monoclonal antibodies (tau1 and tau49) to identify tau in
sympathetic neurons cultured for 1 d. In whole-cell SDS extracts, both
tau-3 and tau-5 recognized a complex set of bands that was also
revealed by the monoclonal antibodies against tau (Fig.
1B-D). These bands included ~6 tau isoforms that ranged
in molecular mass from 45 to 60 kDa and a higher molecular mass species
of 110 kDa. The high molecular weight tau bands account for ~12%
(n = 9, range 5-25%) of the total immunoreactivity in
these blots. Note that the lower molecular weight tau expressed by
these neurons is compositionally more complex than that present in
immature rat brain and closely resembles tau of adult brain in overall
profile. A similar pattern of tau was also detected in 2-week-old
cultures using these polyclonal antibodies (data not shown) as well as
the tau1 monoclonal antibody (Peng et al., 1985 ), except that the high
molecular weight tau was more abundant relative to the low molecular
weight species (the high molecular weight tau comprised ~50% of the
total tau) and the faster migrating species of the low molecular weight
taus were not apparent in older neurons.
The association of tau with MTs is very sensitive to conditions of
fixation and extraction
In our previous studies (Black et al., 1994 ), many features of
MAP1b localization and MT binding were revealed especially clearly by
immunostaining of neurons processed by a combined fixation and
extraction protocol using PHEM containing 2% paraformaldehyde, 0.05%
glutaraldehyde, and 0.5% Triton X-100 (see Figs. 1 and 6 in Black et
al., 1994 ). Surprisingly, when this same procedure was used to
visualize tau in growing axons, we observed little specific tau
staining at all, even though MTs were well preserved and strongly
stained for -tubulin and MAP1b (data not shown). The same negative
results were also obtained when the fixative concentrations were
doubled to 4% paraformaldehyde + 0.1% glutaraldehyde. The lack of tau
staining under these conditions is attributable to the quantitative
extraction of tau from the neurons. This conclusion derives from
biochemical analyses of neurons extracted with Triton X-100 under MT
stabilizing conditions; 99% of the tau was Triton-soluble whereas,
by comparison, only ~54% of MAP1b was Triton-soluble (Fig.
2). Many possible explanations can account for the lack
of tau association with MTs under these conditions. As we document
below, tau binding to MTs in these neurons is very labile to a variety
of conditions of fixation and extraction that preserve MTs and MAP1b
association with MTs.
Fig. 2.
Immunoblot analyses of tau partitioning during
extraction with an MT-stabilizing buffer containing Triton X-100. Cells
were extracted with PHEM + 0.2% Triton X-100 + 10 µM taxol as described in Materials and Methods
to obtain Triton-soluble and Triton-insoluble fractions, which contain
unassembled and assembled MT proteins, respectively. The entire
Triton-soluble and Triton-insoluble fractions were resolved on 4-10%
gradient gels and then transferred to nitrocellulose. The transfer was
first probed with the tau monoclonal cocktail and then, after obtaining
the necessary exposures, the transfer was stripped and reprobed with
the anti-MAP1b polyclonal antibody. Shown are portions of the resulting
exposures showing the partitioning of tau and MAP1b between the
Triton-soluble (S) and Triton-insoluble (I)
fractions. Note that the middle portion of the immunoblot is shown for
tau, whereas the top portion is shown for MAP1b.
[View Larger Version of this Image (57K GIF file)]
We tested several different procedures to visualize tau in cultured
neurons using immunofluorescence procedures. Figure
3A-F shows representative results obtained
with a modified combined fixation and extraction procedure in which
0.2% saponin was used in place of 0.5% Triton X-100 (procedure 1);
comparable results were also obtained when cells were fixed in the
absence of detergent and then permeabilized using procedure 2 or the
PBS/sucrose fixative described by Mandell and Bankler (1995) (data not
shown). All of these procedures resulted in strong staining for tubulin
and tau in the cell body and all along the axon, and the tau staining
could be completely blocked by preincubating the anti-tau antibody with
a boiled MAP fraction prepared from neonatal rat brain (data not
shown). However, in spread regions where MTs were clearly visible by
tubulin staining, tau staining was diffuse and did not colocalize with
the MTs (see Fig. 3C-F). This lack of colocalization was
observed wherever MTs could be seen, including in lamellapodial
expansions of the cell body, in spread regions that occurred
occasionally along the axon shaft, and in the growth cone. Using this
same combined fixation and extraction procedure, MAP1b clearly and
unambiguously colocalized with axonal MTs (see Fig. 3G-J),
as did MAP2 in immature axons (Fig. 4C,D);
tau did not localize to MTs in such immature axons (data not
shown).
Fig. 3.
Double-staining of neurons for tubulin and either
tau (A-F) or MAP1b (G-J). The cells were
processed according to procedure 1 and then stained using staining
condition 1. A, C, E, G, and I show tubulin
staining; B, D, and F show tau staining; and
H and J show MAP1b staining. A and
B show low-magnification images (scale bar, 56 µm)
depicting the overall distribution of tubulin and tau in the neurons,
whereas the remaining panels show higher-magnification views that
reveal details of MT staining for tubulin, tau, and MAP1b under these
fixation and staining conditions. Note that tubulin and tau are
distributed throughout the axon but that tau does not colocalize with
MTs in the growth cone, whereas MAP1b clearly decorates MTs in the
growth cone to or near their tips (see also Black et al., 1994 ). Scale
bar: A, B, 56 µm; C, D, G,
H, 13 µm; E, F, I, J, 3 µm.
[View Larger Version of this Image (81K GIF file)]
Fig. 4.
Double-staining of neurons for -tubulin
(A, C) and MAP2 (B, D). The cells were processed
according to procedure 1 and then processed using staining condition 1. A and B show low-magnification views (scale bar,
56 µm) of typical neurons in 1-d-old cultures stained for tubulin and
MAP2; the arrowheads identify the tip of the axon. Only
faint staining of the axon for MAP2 is apparent, and this is seen in
the proximal part of the axon. However, some neurons have relatively
short axons with large growth cones that we presume are relatively
immature. In these axons (C, D), MAP2 staining is more
apparent than in the more typical axons, and it clearly colocalizes
with MTs in spread regions where MTs can be visualized. Tau staining of
similar axons does not show MT colocalization. Scale bar: C,
D, 13 µm.
[View Larger Version of this Image (59K GIF file)]
One possible interpretation for the lack of tau localization to MTs is
that little or none of the tau associates with MTs. It is also possible
that tau associates with MTs but that the conditions of fixation and
extraction, while preserving tau in the cells, did not preserve its
association with MTs. Because tau is a known MT binding protein (for
review, see Wiche et al., 1991 ), we favored the latter possibility.
This view was confirmed in subsequent experiments that processed cells
by combined fixation and extraction using PEM + 0.5% NP-40 + 0.3%
glutaraldehyde (Lee and Rook, 1992 ). When cultured sympathetic neurons
were processed according to this procedure (procedure 3 in Materials
and Methods) and then double-stained for tubulin and tau, tau clearly
and unambiguously colocalized with MTs in the growth cone (Fig.
5C,D; see also Fig. 8) and also in spread
regions that occurred along the axon (data not shown) (see also DiTella
et al., 1994 ). Tau also localized to MTs in cells fixed with PEM + 0.3% glutaraldehyde without detergent (procedure 4, see Fig.
5G,H). With these latter conditions, the MT localization of
tubulin and tau was superimposed on a diffuse background due presumably
to unassembled tubulin and tau. Because this diffuse staining was much
less apparent in cells fixed in the presence of detergent (Figs. 5,
compare C and D with G and
H), we assume that unassembled tubulin and tau are at least
partially removed from the cells during fixation in the presence of
detergent [experiments using MT depolymerizing agents confirm this
interpretation (see below)]. With fixation in the presence or absence
of detergent, individual MTs stained uniformly along their length for
-tubulin. However, MT staining for tau exhibited a patchy appearance
that presumably reflects the periodicity of tau binding along the
length of the MTs.
Fig. 5.
Double-staining of neurons for tubulin (A,
C, E, G) and tau (B, D, F, H) in cells processed
according to staining condition 2. A-D show low- and
high-magnification views of cells processed using the combined fixation
and extraction procedure of Lee and Rook (1992) (procedure 3).
E-H show low- and high-magnification views of cells fixed
without extraction according to procedure 4. Both procedures reveal
that tau and tubulin staining are more intense in the distal part of
the axon compared to its more proximal regions (see text for additional
details), and that tau colocalizes with MTs in the growth cone (see
C, D, G, and H and Fig. 8). Scale bar in
A = 56 µm and indicates scale in all low-magnification
views (A, B, E, F). Scale bar in C = 13 µm and
indicates scale in all high-magnification views (C, D, G,
H).
[View Larger Version of this Image (106K GIF file)]
Fig. 8.
Tau association with MTs in the growth
cone. High-magnification views of growth cones were processed by
combined fixation and extraction (according to procedure 3) and then
double-stained for -tubulin and tau using staining condition 1. Staining of two different growth cones is shown. A and
D depict tubulin staining, B and E
show tau staining, and C and F show pseudocolor
representations of ratio images obtained by dividing, pixel by pixel,
the image of tau staining by the image of tubulin staining. In the
color key, red corresponds to relatively high ratios,
whereas violet corresponds to relatively low ratios. The
growth cone shown in A-C is representative of many growth
cones examined, and shows that tau associates with MTs to or very near
their tips, with no obvious decline in tau levels along the length of
the MTs. The growth cone shown in D-F shows a distinct
pattern that also occurred commonly in the cultures in which tau
staining of growth cone MTs declines to near background levels over the
distal few micrometers of the MTs. Scale bar, 13 µm.
[View Larger Version of this Image (142K GIF file)]
The above results were obtained with the rabbit antibody against the
N-terminal region of tau (tau-5 ), and qualitatively similar results
were obtained when the antibody was used at dilutions ranging from
1:200 to 1:3000. That the staining pattern is specific for tau is
further indicated by the observations that qualitatively similar
staining patterns were also obtained with a polyclonal antibody against
tau directed against its C-terminal region (tau-3 ) and with monoclonal
antibodies against tau (a cocktail consisting of tau1, tau14, and
tau60; data not shown). We note, however, that staining with the
monoclonal antibodies was less intense than that obtained with the
polyclonal antibodies.
The procedures that resulted in strong tau staining without MT
colocalization used PHEM + saponin as the basic buffer and a mixture of
glutaraldehyde and paraformaldehyde (0.1 and 4%, respectively) for
fixation, whereas the procedures that resulted in both strong staining
and clear colocalization of tau with MT used PEM + NP40 as the buffer
and only glutaraldehyde, at 0.3%, as the fixative. We tested different
combinations of these buffers and fixatives to determine how they
influence tau staining. Using the combination of glutaraldehyde and
paraformaldehyde always resulted in diffuse tau staining without MT
colocalization, regardless of the buffer used, and increasing the
glutaraldehyde concentration to 0.3 or 0.5% did not change this
result. Using 0.3% glutaraldehyde in PEM or PHEM resulted in clear tau
colocalization to MTs. Although we did not pursue these experiments in
detail, the available information indicates that paraformaldehyde
interferes with the preservation of tau in cultured sympathetic
neurons, even in the presence of more potent fixatives such as
glutaraldehyde, such that the association of tau with MTs is lost even
though tau is fixed in the cells.
The above findings show that the specific staining patterns obtained
for tau depend on the specific conditions of fixation and extraction
and that conditions that preserve MTs and reveal MAP1b and MAP2
localization to MTs do not necessarily reveal tau or tau binding to
MTs. Indeed, we have identified conditions that result in clear MAP1b
localization to MTs and either no tau staining whatsoever, or strong
tau staining but no apparent colocalization with MTs. It is only with
procedures 3 and 4 that we have been able to visualize tau associated
with MTs. Whereas these results are primarily technical in nature, they
also indicate that the interaction of tau with MTs differs from that of
MAP1b and MAP2. Such differences are not unexpected for tau and MAP1b
because they have very different MT binding domains (for review, see
Wiche et al., 1991 ). However, tau and MAP2 have highly homologous MT
binding domains, and it would have been reasonable to expect that they
would behave similarly under the experimental conditions tested above.
The finding that tau localization to MTs is more sensitive to the
conditions of extraction and fixation than MAP1b or MAP2 suggests that
tau has a more labile interaction with MTs in these growing axons than
does MAP1b or MAP2. It is not known whether this reflects intrinsic
differences between tau and these other MAPs or the action of
regulatory mechanisms that differentially influence the interactions of
these MAPs with MTs. In this regard, tau in immature CNS neurons only
contains three MT binding repeats (for review, see Wiche et al., 1991 )
and also undergoes posttranslational modifications that reduce its
affinity for MTs (Bramblett et al., 1993 ).
Given the sensitivity of tau localization patterns to fixation
conditions, it is not possible to determine how accurately any given
procedure reflects the true localization within the cell. We assume
that of all the methods tested, the picture of tau localization
provided by procedures 3 and 4 provides the most reliable picture of
tau localization in growing axons because of its ability to
consistently reveal tau association with MTs. Accordingly, we have used
these procedures to examine in detail the localization and MT
association of tau in growing axons.
Tau localization in growing axons
We quantified several parameters of tubulin and tau
distribution in growing axons based on low-magnification images of
neurons fixed and then permeabilized (procedure 4). Representative
images of cells processed in this way are shown in Figure
5E-H. In the vast majority of neurons, the staining
intensity of both tubulin and tau varied along the length of the axon
(Figs. 5, 6, Table 1). Staining for both
tubulin and tau was highest in the cell body. Moving out from the cell
body into the axon, staining intensity declined rapidly, over a
distance of 30-50 µm, to a relatively low value that remained more
or less constant until the distal one-half to one-third of the axon,
where the staining intensity for both tubulin and tau began to
increase, reaching a peak that was, on average, 20-50 µm from the
axon tip. As a measure of the magnitude of the proximal-to-distal
increase in the amount of tubulin and tau in the axon, we expressed the
peak values in the distal axon relative to the average values in the
proximal axon. Tubulin levels increased ~6-fold, whereas tau
increased ~11-fold (see Table 1). These results reveal a
proximal-to-distal gradient in the amount of tau and tubulin within the
axon, with the amount tau and tubulin rising steadily in the distal
part of the axon to reach a peak near the growth cone.
Comparison of tubulin and tau in terms of the ratio of the peak
staining intensity in the distal axon to the mean in the axon shaft
reveals that the magnitude of the distal increase in tau staining
exceeds that for tubulin. This point is made more dramatically in plots
of the ratio of tau fluorescence to tubulin fluorescence along the
length of the axon (see Fig. 6C,F). In all but one axon
analyzed quantitatively (13 of 14 axons), these plots showed a
progressive proximal-to-distal increase in the amount of tau relative
to tubulin along the length of the axon. As a measure of the magnitude
of this increase, the peak ratio in the distal axon was, on average,
3.7 + 1.9 µm (mean ± SD, range = 1.7-8.6) times the average in the
plateau region of the axon shaft. Because the method of fixation
followed by permeabilization (procedure 4) preserves all of the tubulin
and all of the tau in the cells, these data show that the amount of
total tau relative to total tubulin increases progressively along the
length of the axon.
The proximal-to-distal increase in the amount of tau reflects a
corresponding increase in tau concentration. This was determined by
normalizing the tau fluorescence along the axon to axon volume in cells
fixed and then permeabilized (Fig. 7). In 12 of 14 cells, the volume density of tau increased in a proximal-to-distal
manner to reach a peak near the growth cone that was, on average, 3.5 ± 1 (range = 2.2-5) times greater than the average in the axon shaft.
In the two axons that did not show a distal increase in the volume
density of tau, this parameter was more or less uniform along the
length of the axon. Thus, the proximal-to-distal increase in the amount
of tau typically reflects an increase in its concentration.
With regard to tubulin, 10 of 14 neurons showed either no change or a
slight decline in the volume density of tubulin along the axon. In the
remaining four neurons, the volume density of tubulin increased in the
distal part of the axon, reaching a peak that was on average ~2 times
that observed more proximally. In axons that showed a distal increase
in the volume density of both tubulin and tau, the magnitude of the
increase for tau always exceeded that for tubulin.
Tau binding to MTs in the growth cone
High-magnification images of growth cones double-stained for
tubulin and tau reveal that tau is present on MTs in the growth cone.
In approximately half of the well spread growth cones observed, tau
staining of MTs extended to or near their tips (Fig. 8;
see also DiTella et al., 1994 ). Such colocalization of tau with MTs was
seen with the antibody directed against the N terminus of tau as well
as the C terminus (data not shown). In the remaining growth cones, MT
staining for tau declined between the central and peripheral regions of
the growth cone, and for many MTs, tau was absent from their most
distal several (3-5) micrometers; this pattern was revealed especially
well in ratio images prepared by dividing the tau stained image by the
tubulin stained image (Fig. 8C,F). The basis for this
variation in tau staining of growth cone MTs is not known.
Behavior of tau during detergent extraction under MT stabilizing
conditions: immunofluorescence and biochemical analyses
We attempted to use extracted cell models prepared under MT
stabilizing conditions to evaluate the relative content of tau on MTs
along the length of the axon. Initially, we used extraction conditions
(PHEM or PEM + 0.2% saponin + 10 µM taxol; see
Materials and Methods) that preserve MTs as well as MAP1b binding to
MTs in extracted cells (Black et al., 1994 ). With these conditions, tau
staining along the axon was at best barely detectable (data not shown).
We also tested several other extraction conditions, such as including
33% (v/v) glycerol in the extraction buffer, using MES-based buffers,
and extracting at 37°C versus at room temperature. Each of these
extraction procedures was also evaluated using three different
fixatives (see procedures 1, 3, and 4). In none of these conditions was
any appreciable tau staining observed along the axon or in the growth
cone.
One possible explanation for the lack of tau staining in these
cytoskeletal preparations is that the tau dissociates from MTs during
extraction and is removed from the cells. This interpretation is also
consistent with the finding that tau binding to MTs is lost under a
variety of conditions of combined fixation and extraction (see Fig. 3
and above). Previously we showed that a portion of the tau in 10- to
14-d-old cultures of sympthetic neurons partions with MTs during
extraction under MT stabilizing conditions (Peng et al., 1985 ).
However, these experiments did not examine the proportion of total tau
that partitioned with MTs versus soluble fraction. In the present
experiments, we used biochemical procedures to evaluate the
partitioning of tau between soluble and cytoskeletal fractions. As
shown in Figure 9, the vast majority of the tau was
soluble after extraction with PEM containing 0.2% saponin + taxol.
Quantitative analyses reveal that 90% (mean, n = 4) of the
total tau is solubilized under these conditions, whereas only 10%
remains associated with MTs (or other insoluble components). It is
highly unlikely that this relatively small amount of the total tau
represents the actual amount associated with MTs in the axon given that
staining of MTs for tau is so much stronger than that observed in
regions devoid of MTs (see Fig. 5G,H). Thus, the biochemical
data support the interpretation that tau dissociates from MTs during
extraction with nonionic detergents [Triton X-100 (Fig. 2) and
saponin] and is then removed from the cells.
Fig. 9.
Immunoblot analyses of tau partitioning during
extraction with an MT-stabilizing buffer containing saponin. Cells were
extracted with PEM + 0.2% saponin + 10 µM
taxol as described in Materials and Methods to obtain saponin-soluble
and saponin-insoluble fractions, which contain unassembled and
assembled MT proteins, respectively. The entire amount of each fraction
was resolved on 4-10% gradient gels, transferred to nitrocellulose,
and then probed with the anti-tau polyclonal (tau-3 ). Shown is a
portion of a resulting exposure showing the partitioning of tau between
the saponin-soluble (S) and saponin-insoluble (I)
fractions. In this experiment, 96% of the tau partitioned with the
saponin-soluble fraction. In three other experiments performed
identically, 66, 99, and 99% of the total tau partitioned with the
saponin-soluble fraction. The basis for the apparently spuriously low
result in one of four experiments is unknown.
[View Larger Version of this Image (32K GIF file)]
Tau is enriched on MTs in the distal part of the axon
Although we could not evaluate tau assembled into MTs using
extracted cell models, the following results indicate that in cells
processed by combined fixation and extraction (procedure 3), the
staining for tau and tubulin is attributable principally to tau and
tubulin assembled into MTs. First, the amount of diffuse staining for
tubulin and tau observed in spread regions of cells processed by
combined fixation and extraction is much less than that seen in
comparable regions of cells fixed in the absence of detergent (see Fig.
5, compare C and D with G and
H). Assuming that the diffuse staining corresponds to
unassembled tubulin and tau, then the relative lack of diffuse staining
in cells processed by combined fixation and extraction indicates that
unassembled tubulin and tau are removed from the cells and that the
remaining staining corresponds to assembled forms of these
proteins.
To directly test this possibility, cells were treated with 5 µg/ml
nocodazole for 30 min to depolymerize their MTs and then processed by
combined fixation and extraction. If unassembled tubulin and tau are
not extracted, then the intensity of tubulin and tau staining will
resemble that observed in control cells. On the other hand, if
unassembled tubulin and tau are extracted during the combined fixation
and extraction procedure, then tubulin and tau staining will be
substantially diminished relative to controls. As shown in Figure
10, staining for tubulin and tau is dramatically
reduced in drug-treated neurons compared to control neurons (compare
A and B with C and D).
Quantitative analyses reveal that the drug treatment reduced the
intensity of axonal staining for tubulin and tau by 90% and 95%,
respectively (based on analyses of three control axons and four
drug-treated axons). More detailed inspection reveals that staining for
both tubulin and tau was diminished throughout the axons of
drug-treated cells, including in the distal region, where tubulin and
tau staining are normally relatively high. Also, gaps in tubulin and
tau staining occurred sporadically along drug-treated axons (see
double-headed arrow in Fig. 9G,H), and in some
axons both tubulin and tau staining were at background levels in the
distal axon and growth cone, situations never observed in control
axons. When drug-treated cells were fixed in the absence of detergent
(using procedure 4), staining for tubulin and tau remained strong
throughout the axon (Fig. 10E,F), indicating that drug
treatment did not lead to the wholesale proteolysis of tubulin or tau
over the time course of these experiments (see also Drubin et al.,
1988 ; Black et al., 1989 ). Collectively, these results indicate that
unassembled tubulin and tau are removed from cells processed by
combined fixation and extraction. Therefore, the axonal staining for
tubulin and tau normally seen with this procedure is attributable to
tubulin and tau assembled into MTs.
Fig. 10.
Effects of nocodazole on the intensity of axonal
staining for tubulin and tau. Cells were treated with or without
nocodazole (5 µg/ml) for 30 min, and then processed by combined
extraction and fixation (procedure 3, A-D, G, H) or by
fixation without extraction (procedure 4, E, F),
and then double-stained for tubulin (A, C, E, G) and tau
(B, D, F, H) using staining condition 1. A and
B show a control cell demonstrating typical staining
patterns for tubulin and tau, respectively. The intensity of staining
in drug-treated cells is dependent on the conditions of fixation. With
combined fixation and extraction (C, D), tubulin and tau
staining is reduced to negligible levels compared to controls, whereas
with fixation without extraction, tubulin and tau staining is strong.
The cell shown in C and D is shown again in
G and H, but scaled to better reveal the dim
staining remaining in this cell. Entirely similar results were also
obtained using a modified procedure 3 in which the Triton X-100
treatment after fixation was omitted. Note that staining for tubulin
and tau is at or near background in the distal 30-40 µm of the axon
(see C, D, G, H). The arrowheads identify
non-neuronal cells (non-neuronal cells processed by combined fixation
and extraction and then viewed at higher magnification contain a few
wavy MTs; data not shown), the single-headed
arrows identify the axon tip in drug-treated cells, and the
double-headed arrows identify a gap in
staining along the length of a drug-treated axon.
[View Larger Version of this Image (86K GIF file)]
We used the combined extraction and fixation procedure (procedure 3) to
quantify the relative amounts of assembled tubulin and assembled tau
along the length of growing axons (Fig. 11, Table
2). The overall staining patterns of assembled tubulin
and assembled tau resemble those for total tubulin and total tau.
Specifically, the relative amounts of assembled tubulin and assembled
tau increase progressively in the distal one-half to one-third of the
axon, to reach a peak at variable, though relatively short, distances
from the growth cone; on average, the peak amounts of assembled tubulin
and assembled tau occurred within 30-50 µm from the axon tip. The
proximal-to-distal gradient in assembled tau was steeper than that for
assembled tubulin. As one measure of this, we expressed the peak
staining intensity for assembled tubulin and assembled tau in the
distal axon relative to the average values in the proximal axon. The
relative levels of assembled tubulin increased ~4-fold, whereas the
relative amount of assembled tau increased ~13-fold (see Table
2). As another measure of this, we calculated the ratio of staining
caused by assembled tau to that of assembled tubulin along the length
of the axon (Fig. 11C,F). This ratio was relatively
low and constant in the proximal half of the axon. However, within the
distal half, the amount of assembled tau relative to assembled tubulin
increased progressively to reach a peak near the growth cone; the peak
ratio in the distal axon was, on average, 6.2 ± 2.7 µm (range = 2.8-12.1) times the average in the proximal axon. Thus, the tau
content of MTs (i.e., the amount of tau per unit amount of MT polymer)
increases progressively in a proximal-to-distal direction along the
length of growing axons.
Tau and the stability of MTs in growing axons
Tau influences the assembly and stability of MTs in
vitro and in intact cells. For example, in the test tube, tau
promotes tubulin assembly into MTs and enhances MT stability
principally by reducing the probability that MTs will undergo
depolymerization (Pryer et al., 1992 ; Trinczek et al., 1995 ). In intact
cells, the introduction of high levels of tau increases MT resistance
to depolymerizing drugs (Baas et al., 1994 ; Drubin and Kirschner, 1986;
Takemura et al., 1992 ). If tau has similar functions in growing axons,
then the proximal to distal gradient in the amount of total tau
relative to total tubulin (see Fig. 6) should generate a corresponding
gradient in the extent of tubulin assembly. Similarly, the gradient in
the tau content of MTs (see Fig. 11) should generate a corresponding
gradient in MT resistance to depolymerizing drugs. As shown below, our
data do not support either of these predictions.
To determine whether the sensitivity of axonal MTs to treatment
with MT depolymerizing drugs varies as a function of their content of
tau, neurons treated with 5 µg/ml nocodazole for 0, 10, or 20 min
were fixed (according to procedure 3) and then immunostained to reveal
assembled tubulin and assembled tau. We then used the segmented mask
procedure to quantify the staining intensity attributable to assembled
tubulin and assembled tau in the entire axon and in two discrete
~100-µm-long segments of the axon, one situated proximally and one
situated distally. The distal segment included the most distal ~100
µm of the axon. The proximal segment was situated between 50 and 150 µm from the cell body. The MT polymer in this proximal region has the
lowest average content of tau of the axon, whereas the polymer in the
distal region has a higher tau content, and includes the axonal polymer
with the highest average content of tau. Thus, if the differences in
tau content of the polymer in these regions are sufficient to influence
their sensitivity to MT depolymerizing drugs, then the polymer in these
two regions will decline at distinctly different rates in the presence
of such drugs. However, as shown in Figure 12, the
amount of polymer in the entire axon as well as in proximal and distal
regions decline in the presence of drug, and the time course of the
decline in the distal axon is indistinguishable from that in the
proximal axon. Thus, in spite of the severalfold difference in tau
content, the MT polymer in the proximal and distal axon exhibit very
similar sensitivities to nocodazole.
Fig. 12.
Quantitative analyses of the time course of
nocodazole effects on the amount of MT polymer in the axon. Cultures
were treated with 5 µg/ml nocodazole for 0, 10, or 20 min and
processed by combined extraction and fixation using procedure 3. The
cells were then double-stained for tubulin and tau using staining
condition 1. Images were obtained from the resulting cells and
subjected to the segmented mask procedure to quantify tubulin and tau
staining along the length of the axon. We then computed the total
staining intensity of tubulin and tau for the entire axon, and for a
100 µm segment located proximally, and a 100 µm segment located
distally (10 or 11 axons were measured for each drug treatment
condition). The proximal segment was situated between 50 and 150 µm
from the cell body and contains the polymer that has the lowest average
content of tau in the axon. The distal segment included the most distal
100 µm of the axon and contains polymer that has a much higher tau
content than the polymer in the proximal segment, and includes the
axonal polymer with the highest average content of tau. The staining
intensity for tubulin and tau of drug-treated axons is expressed as a
percentage of the intensity in control axons. These analyses show that
the time course of polymer loss is the same in the proximal and distal
axonal regions in spite of the severalfold difference in tau content of
the polymer in these regions.
[View Larger Version of this Image (32K GIF file)]
Drug treatment also did not detectably affect the ratio of tau
fluorescence to tubulin fluorescence in axonal MTs. We evaluated this
by measuring the average tau-to-tubulin ratio and the maximum
tau-to-tubulin ratio for the entire axon, and for the proximal and
distal regions described above. In control axons, the average values
for this ratio for the entire axon and for the proximal and distal
regions described above were 0.43 ± 0.20 (mean ± SD), 0.25 ± 0.13, and 0.82 ± 0.42, respectively, whereas the maximum values were 1.26 ± 0.64, 0.36 ± 0.19, and 1.26 ± 0.64, respectively. In axons treated
with nocodazole for 20 min, the corresponding average values were 0.54 ± 0.22, 0.28 ± 0.12, and 0.83 ± 0.53, whereas the maximum values
were 1.37 ± 0.64, 0.48 ± 0.17, and 1.13 ± 0.65. If the tau content
of axonal MTs influences the time course of polymer loss in the
presence of drug, then this parameter, as measured by the
tau-to-tubulin ratio, should change as a function of time in drug. For
example, if MT polymer with a relatively high tau content depolymerized
slower than polymer with a relatively low content, then the average and
maximum values for the tau-to-tubulin ratio would increase with time in
drug. Clearly, this is not the case over the time course of the present
experiments. This result further reinforces the conclusion that the
naturally occurring variation in the tau content of the MT polymer in
growing axons does not influence the sensitivity of this polymer to
nocodazole-induced depolymerization.
The proximal-to-distal gradient in the amount of tau relative to
tubulin does not generate a corresponding gradient in the tubulin
monomer-to-polymer ratio
To obtain information on the possible effects of tau on the
assembly of MTs in growing axons, we evaluated whether the proportion
of tubulin in polymer increases along the axon in parallel with the
proximal-to-distal increase in the tau-to-tubulin ratio. We used an
indirect analysis based on the following considerations. Quantitative
analyses of tubulin staining indicates that the amounts of total
tubulin (Fig. 6, Table 1) and of assembled tubulin (Fig. 11, Table 2)
increase in a proximal-to-distal manner for most axons. If the
proportion of the total tubulin pool that is assembled increases along
the length of the axon, then the magnitude of the proximal-to-distal
increase in staining for assembled tubulin (seen in cells processed by
combined fixation and extraction according to procedure 3) will be
greater than that observed for total tubulin (seen in cells fixed and
then permeabilized according to procedure 4). To evaluate this, we
calculated two parameters, the ratio of the peak staining for tubulin
in the distal axon to the mean staining in the proximal axon and the
ratio of the peak staining for tubulin in the distal axon to the median
staining for the entire axon (see Tables 1 and 2). For total tubulin,
these ratios were 6.3 ± 4.1 and 5.1 ± 2.4, respectively, whereas for
assembled tubulin they were 4 ± 2.6 and 3.5 ± 2.2, respectively.
Whereas considerable cell-to-cell variation exists in the values
obtained for these parameters, there is no indication that the values
for the assembled tubulin pool are, overall, greater than (or less
than) those for the total tubulin pool. Thus, the tubulin
monomer-to-polymer ratio does not appear to vary systematically along
the axon in relation to the tau-to-tubulin ratio. This in turn
indicates that the proximal-to-distal increase in the tau-to-tubulin
ratio (see Fig. 6 and above) is not reflected in the extent of tubulin
assembly within these axons.
DISCUSSION
Tau has a nonuniform distribution in axons of cultured sympathetic
neurons. Its levels are relatively low and constant in the proximal
half of the axon. However, within the distal half, the amount of total
tau and assembled tau undergoes a progressive proximal-to-distal
increase, reaching a peak near the growth cone that is ~10-fold
greater than that observed proximally. The volume of the axon also
increases proximodistally. However, the proximodistal increase in total
tau exceeds by severalfold that of axon volume, indicating that the
concentration of tau increases progressively along the axon. The
amounts of total tubulin and assembled tubulin also exhibit a
proximodistal increase. However, the gradients of total tau and
assembled tau are steeper than those of tubulin. Thus, the ratio of
total tau to total tubulin and the tau content of MTs increases
progressively between the proximal axon and the axon tip (Figs. 6,
11).
We have taken advantage of the naturally occurring gradient in the tau
content of MTs and in the ratio of total tau to total tubulin to
evaluate whether tau promotes MT assembly and stability in growing
axons. Functional studies of tau in the test tube and in non-neuronal
cells transfected with tau have revealed several activities of tau,
most notably the ability to promote the assembly of tubulin into MTs
and to enhance the stability of MTs (for review, see Hirokawa, 1994 ).
Based on these activities, it has been proposed that tau promotes the
assembly and stabilization of MTs required for axon growth (Caceres et
al., 1992 ; Brandt and Lee, 1993 ; Esmaeli-Azad et al., 1994 ). If the
stability of axonal MTs is a direct function of their content of tau,
then the most stable polymer of the axon should have the highest
content of tau, and conversely, the most dynamic polymer should have
the least tau. Furthermore, the proximal-to-distal gradient in the
amount of total tau to total tubulin should generate a corresponding
gradient in the proportion of total tubulin assembled into MTs. Our
data do not support either of these predictions. First, the polymer
with the highest content of tau is located in the distal part of the
axon and in the growth cone. This polymer is also among the most
dynamic of the entire axon as measured by its turnover behavior (Lim et
al., 1989 ; Edson et al., 1993 ; Li and Black, 1996 ), its relative
content of tyrosinated -tubulin (Brown et al., 1992 ), and its
sensitivity to MT depolymerizing drugs (Baas et al., 1993 ). Second, the
distribution of tubulin between monomer and polymer is similar in the
proximal and distal parts of the axon, in spite of the severalfold
difference in the amount of total tau relative to total tubulin and in
the tau content of the MT polymer in these regions. Clearly, the
stability of MTs in axons of cultured sympathetic neurons is not
directly related to their relative content of tau, nor is the extent of
tubulin assembly along the axon related to the tau-to-tubulin
ratio.
Other observations also question whether tau promotes MT assembly and
stability in growing axons. First, if tau stabilizes axonal MTs, then
it should have a reasonably stable interaction with these MTs (Trinczek
et al., 1995 ). However, we found that the interaction of tau with MTs
is quite labile under a variety of conditions that preserve MTs and the
interaction of MAP1b and MAP2 with MTs. Second, if tau is crucial for
MT assembly and stability, then changing the levels of tau should have
concomitant effects on MT polymer levels. In several cases, however,
this was not observed. For example, suppression of tau expression in
cultured cerebellar neurons using antisense probes had minimal effect
on MT polymer levels (Caceres et al., 1992 ), whereas overexpressing tau
had no effect on the tubulin monomer-polymer distribution in PC12
cells grown without NGF (Esmaeli-Azad et al., 1994 ) and in non-neuronal
cells (Barlow et al., 1994 ). In other cases, a positive correlation
between changing levels of tau expression and MT assembly and stability
has been reported. Most notably, in PC12 cells treated with NGF, the
amounts of tau and MTs increase over a similar time course (Drubin et
al., 1985 ; Esmaeli-Azad et al., 1994 ). However, many other changes
occur in these cells during this time, including enhanced expression
and phosphorylation of other MAPs (Drubin et al., 1985 ; Black et al.,
1986 ; Brugg and Matus, 1988 ). Thus, the contribution of the enhanced
expression of tau to the increase in MT mass is uncertain.
Given that tau promotes MT assembly and stability in vitro
(for review, see Hirokawa, 1994 ), it is unexpected that the
proximodistal gradient in the tau content of MTs does not generate a
corresponding gradient in the stability of axonal MTs. Perhaps the
molar ratio of tau to tubulin is too low to appreciably affect MT
dynamics in growing axons. However, when measured in cells extending
axons (Drubin et al., 1985 ; Ferreira et al., 1989 ), this parameter was
within the effective range for promoting assembly in vitro.
Another possibility relates to the developmental regulation of tau. Tau
consists of a variety of isoforms caused by alternative splicing and
phosphorylation (for review, see Wiche et al., 1991 ). Both the
alternative splicing and phosphorylation of tau are developmentally
regulated such that tau in immature neurons differs dramatically in
composition from that in mature neurons. Most studies that have
examined tau in vitro have used tau from adult brain. This
tau may be very different from tau in immature neurons in terms of its
assembly promoting and stabilizing activities. In this regard, one of
the alternative splicing events that is developmentally regulated
affects the MT binding domain of tau such that its intrinsic affinity
for MTs is greater in mature neurons compared to immature neurons
(Goode and Feinstein, 1994 ; Trinczek et al., 1995 ). Also, some of the
sites preferentially phosphorylated in immature neurons reduce the
assembly competence of tau in vitro (Bramblett et al.,
1993 ). Thus, tau in growing neurons is subject to multiple regulatory
mechanisms that reduce its affinity for MTs and its assembly promoting
and stabilizing activities. This in turn may contribute to the observed
lability of tau's interaction with MTs, and to its apparently limited
affect on MT assembly and stability in growing axons. Implicit in this
view is that in mature axons, tau does influence MT assembly and
stability. Whereas this possibility provides an attractive explanation
for the limited effects of tau on MT assembly and stability observed in
growing axons, tau in young cultures of sympathetic neurons is more
like that of adult brain than fetal brain in its gel profile. Thus, it
is unclear exactly how tau in these neurons differs from that in mature
brain. Finally, it is also possible that the functions of tau in
vivo differ from those inferred from test tube experiments. In
this regard, gene disruption experiments indicate that tau is not
essential to generate axons that contain an apparently normal MT array
(Harada et al., 1994 ).
The issues concerning whether tau promotes MT assembly and stability in
growing axons also apply to other MAPs. Tau is only one of several MAPs
in growing axons (Black and Smith, 1988 ), and at least one other MAP,
namely MAP1b, is also enriched by severalfold on MTs in the distal part
of growing axons (Black et al., 1994 ). In fact, most and possibly all
MTs in the growth cone contain both MAP1b and tau (Figs. 3, 5, 8; Black
et al., 1994 ). Thus, in this region, both tau and MAP1b are present on
the same MTs, and at severalfold higher levels than on MTs situated
more proximally in the axon. In spite of their relatively high levels
of at least two different MAPs, the MT polymer in the distal axon is
not endowed with enhanced stability compared to the polymer situated
more proximally. Indeed, just the opposite is observed; this polymer is
the most dynamic of the entire axon. Thus, binding of tau and MAP1b to
MTs at the levels that naturally occur in the distal axon and growth
cone does not preclude this polymer from undergoing relatively dynamic
behavior.
What are the functional specializations of tau and MAP1b in growing
axons? The answer still remains a mystery. Given that both MAP1b and
tau are MT binding proteins, it seems reasonable that their functions
in axon growth are MT dependent and involve at least in part binding to
MTs. In addition, both tau and MAP1b have sidearm domains that project
away from the surface of the MT. Through their sidearm domains, tau and
MAP1b influence the packing density of MTs (Bloom et al., 1985 ; Black,
1988; Chen et al., 1992 ) and may also interact with other structures
including MTs, intermediate filaments, microfilaments, the plasma
membrane, and internal membrane systems (DiTella et al., 1994 ; Brandt
et al., 1995 ) (for review, Schoenfeld and Obar, 1994 ). This variety of
potential binding partners in vivo raises the possibility
that tau and other MAPs function to integrate MTs with other
cytoplasmic structures. The observations that tau, MAP1b, and possibly
other MAPs are preferentially concentrated in the distal axon and
growth cone and that the MT polymer in this region is especially
enriched in these MAPs focus attention on these distal regions as key
sites of MAP function in elongating axons. The distal region of growing
axons is the most newly formed part of the axon. Perhaps tau and other
MAPs, by mediating the interaction of MTs with other structures, help
to consolidate the internal architecture of the newly formed axon so
that it can continue to elongate.
FOOTNOTES
Received Feb. 8, 1996; revised March 5, 1996; accepted March 6, 1996.
This work was supported by National Institutes of Health Grants NS17681
(M.M.B.) and NS24275 and NS24707 (I.F.). We thank Jonathan Fischer for
his skilled technical assistance with computer analyses of gel
images.
Correspondence should be addressed to Dr. Mark M. Black, Department of
Anatomy and Cell Biology, Temple University School of Medicine, 3400 North Broad Street, Philadelphia, PA 19140.
REFERENCES
-
Ahmad FJ,
Pienkowski TP,
Baas PW
(1993)
Regional
differences in microtubule dynamics in the axon.
J Neurosci
13:856-866 .
[Abstract]
-
Baas PW,
Ahmad FJ,
Pienkowski TP,
Brown A,
Black MM
(1993)
Sites of stabilization for axonal microtubules.
J Neurosci
13:2177-2185 .
[Abstract]
-
Baas PW,
Pienkowski TP,
Cimbalnik KA,
Toyama K,
Bakalis S,
Ahmad FJ,
Kosik KS
(1994)
Tau confers drug-stability but not
cold-stability to microtubules in living cells.
J Cell Sci
107:135-143 .
[Abstract]
-
Barlow S,
Gonzalez-Garay ML,
West RR,
Olmsted JB,
Cabral F
(1994)
Stable expression of heterologous
microtubule-associated proteins (MAPs) in chinese hamster ovary cells:
evidence for differing roles of MAPs in microtubule organization.
J Cell Biol
126:1017-1029 .
[Abstract/Free Full Text]
-
Black MM
(1987)
Comparison of MAP-2 and tau on the packing
density of assembled microtubules.
Proc Natl Acad Sci USA
84:7783-7787 .
[Abstract/Free Full Text]
-
Black MM
(1994)
Microtubule assembly and transport cooperate
to generate the microtubule array of the axon.
Prog Brain Res
102:61-77 .
[Web of Science][Medline]
-
Black MM,
Kurdyla JT
(1983)
Microtubule-associated proteins
of neurons.
J Cell Biol
97:1020-1028 .
[Abstract/Free Full Text]
-
Black MM,
Smith W
(1988)
Regional differentiation of the
neuronal cytoskeleton, with an appendix: diffusion of proteins in the
neuron cell body: mathematical approximations and computer simulations.
In: Intrinsic determinants of neuronal form and function
(Lasek, RJ,
Black, MM,
eds)
, p. 463. New York: Liss.
-
Black MM,
Cochran JM,
Kurdyla JT
(1984)
Solubility properties
of neuronal tubulin: evidence for labile and stable microtubules.
Brain Res
295:255-263 .
[Web of Science][Medline]
-
Black MM,
Aletta J,
Greene LA
(1986)
Regulation of
microtubule composition and stability during nerve growth
factor-promoted outgrowth.
J Cell Biol
103:545-557 .
[Abstract/Free Full Text]
-
Black MM,
Baas PW,
Humphreys S
(1989)
Dynamics of
-tubulin
deacetylation in cultured neurons.
J Neurosci
9:358-368 .
[Abstract]
-
Black MM,
Slaughter T,
Fischer I
(1994)
Microtubule-associated protein 1b (MAP1b) is
concentrated in the distal region of growing axons.
J Neurosci
14:857-870 .
[Abstract]
-
Bloom GS,
Luca FC,
Vallee RB
(1985)
Microtubule associated
protein 1B: identification of a major component of the neuronal
cytoskeleton.
Proc Natl Acad Sci USA
82:5404-5408 .
[Abstract/Free Full Text]
-
Blose SH,
Meltzer DI,
Feramisco JR
(1984)
10 nm filaments are
induced to collapse in living cells microinjected with monoclonal and
polyclonal antibodies against tubulin.
J Cell Biol
98:847-858 .
[Abstract/Free Full Text]
-
Bramblett GT,
Goedert M,
Jakes R,
Merrick SE,
Trojanowski JQ,
Lee VM-Y
(1993)
Abnormal tau phosphorylation at
Ser396 in Alzheimer's disease recapitulates
development anmd contributes to reduced microtubule binding.
Neuron
10:1089-1099 .
[Web of Science][Medline]
-
Brandt R,
Lee G
(1993)
The balance between tau protein's
microtubule growth and nucleation activities: implications for the
formation of axonal microtubules.
J Neurochem
61:997-1005 .
[Web of Science][Medline]
-
Brandt R,
Leger J,
Lee G
(1995)
Interaction of tau with the
neural plasma membrane mediated by tau's amino-terminal projection
domain.
J Cell Biol
131:1327-1340 .
[Abstract/Free Full Text]
-
Brown A,
Slaughter T,
Black MM
(1992)
Newly assembled
microtubules are concentrated in the proximal and distal regions of
growing axons.
J Cell Biol
119:867-882 .
[Abstract/Free Full Text]
-
Brown A,
Li Y,
Slaughter T,
Black MM
(1993)
Composite
microtubules of the axon: quantitative analysis of tyrosinated and
acetylated
-tubulin along axonal microtubules.
J Cell Sci
104:339-352 .
[Abstract]
-
Brugg B,
Matus A
(1988)
PC12 cells express juvenile
microtubule-associated proteins during nerve growth factor-induced
neurite outgrowth.
J Cell Biol
107:643-650 .
[Abstract/Free Full Text]
-
Caceres A,
Kosik KS
(1990)
Inhibition of neurite polarity by
tau antisense oligonucleotides in primary cerebellar neurons.
Nature
343:461-463 .
[Medline]
-
Caceres A,
Mautino J,
Kosik KS
(1992)
Suppression of MAP2 in
cultured cerebellar macroneurons inhibits minor neurite foramtion.
Neuron
9:607-618 .
[Web of Science][Medline]
-
Carlier MF,
Simon C,
Cassoly R,
Pradel LA
(1984)
Interactions
between microtubule-associated protein tau and spectrin.
Biochimie
66:305-311 .
[Medline]
-
Chen J,
Kanai Y,
Cowan NJ,
Hirokawa N
(1992)
Projection
domains of MAP2 and tau determine spacings between microtubules in
axons and dendrites.
Nature
360:674-677 .
[Medline]
-
Chomcynski P,
Sacchi N
(1987)
Single step method for RNA
isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.
Anal Biochem
162:156-159.
[Web of Science][Medline]
-
DiTella M,
Feiguin F,
Morfini G,
Caceres A
(1994)
Microfilament-associated growth cone component
depends upon tau for its intracellular localization.
Cell Motil Cytoskeleton
29:117-130 .
[Web of Science][Medline]
-
Drubin DG,
Kirschner M,
W
(1986)
Tau protein function in
living cells.
J Cell Biol
103:2739-2746 .
[Abstract/Free Full Text]
-
Drubin DG,
Feinstein SC,
Shooter EM,
Kirschner MW
(1985)
Nerve growth factor induced outgrowth in PC12 cells
involves the coordinate induction of microtubule assembly and assembly
promoting factors.
J Cell Biol
101:1799-1807 .
[Abstract/Free Full Text]
-
Drubin D,
Kobayashi S,
Kellogg D,
Kirschner M
(1988)
Regulation of microtubule protein levels during
cellular morphogenesis in nerve growth factor-treated PC12 cells.
J Cell Biol
106:1583-1591 .
[Abstract/Free Full Text]
-
Edson KJ,
Lim S-S,
Borisy GG,
Letourneau PC
(1993)
FRAP
analysis of the stability of the microtubule population along the
neurites of chick sensory neurons.
Cell Motil Cytoskeleton
25:59-72 .
[Web of Science][Medline]
-
Esmaeli-Azad B,
McCarty JH,
Feinstein SC
(1994)
Sense and
anti-sense transfection analysis of tau function: tau influences net
microtubule assembly, neurite outgrowth, and neuritic stability.
J Cell Sci
107:869-879 .
[Abstract]
-
Ferreira A,
Busciglio J,
Caceres A
(1989)
Microtubule
foramtion and neurite growth in cerebellar macroneurons which develop
in vitro: evidence for the involvement of microtubule
associate proteins MAP1a, HMW-MAP2, and tau.
Dev Brain Res
49:215-228 .
[Medline]
-
Fischer I,
Romano-Clarke G
(1991)
Association of
microtubule-associated protein (MAP1B) with growing axons in cultured
hippocampal neurons.
Mol Cell Neurosci
2:39-51.
-
Goedert M,
Spillantini MG,
Crowther RA
(1992)
Cloning of big
tau microtubule-associated protein characteristic of the peripheral
nervous system.
Proc Natl Acad Sci USA
89:1983-1987 .
[Abstract/Free Full Text]
-
Goode BL,
Feinstein SC
(1994)
Identfication of a novel
microtubule binding ans assembly domain in the developmentally
regulated inter-repeat region of tau.
J Cell Biol
124:769-782 .
[Abstract/Free Full Text]
-
Griffith H,
Pollard TD
(1982)
The interactin of actin
filaments with microtubules and microtubule associated proteins.
J Biol Chem
257:9143-9151.
[Abstract/Free Full Text]
-
Gundersen GG,
Khawaja S,
Bulinski JC
(1987)
Post-polymerization detyrosination of
-tubulin:
a mechanism for subcellular differentiation of microtubules.
J Cell Biol
105:251-264 .
[Abstract/Free Full Text]
-
Hanemaaijer R,
Ginzberg I
(1991)
Involvement of mature tau
isoforms in the stabilization of neurites in PC12 cells.
J Neurosci Res
30:163-171 .
[Web of Science][Medline]
-
Harada H,
Oguuchi K,
Okabe S,
Kuno J,
Terada S,
Oshima T,
Sato-Yoshitake R,
Takel Y,
Noda T,
Hirokawa N
(1994)
Altered
microtubule organization in small-caliber axons of mice lacking tau
protein.
Nature
369:488-491.
[Medline]
-
Hirokawa N
(1994)
Microtuble organization and dynamics
dependent on microtubule-associated proteins.
Curr Opin Cell Biol
6:74-81 .
[Web of Science][Medline]
-
Knops J,
Kosik KS,
Lee G,
Pardee JD,
Cohen GL,
McConlogus L
(1991)
Overexpression of tau in nonneuronal cells induces
long cellular processes.
J Cell Biol
114:725-733 .
[Abstract/Free Full Text]
-
Kotani S,
Hishida E,
Kumagai H,
Sakai H
(1985)
Calmodulin
inhibits the interaction of actin with MAP2 and tau, two major
microtubule associated proteins.
J Biol Chem
260:10779-10783 .
[Abstract/Free Full Text]
-
Lee G
(1993)
Non-motor microtubule-associated proteins.
Curr Opin Cell Biol
5:88-94 .
[Medline]
-
Lee G,
Rook SL
(1992)
Expression of tau protein in
nonneuronal cells: microtubule binding and stabilization.
J Cell Sci
102:227-237 .
[Abstract/Free Full Text]
-
Leger JG,
Brandt R,
Lee G
(1994)
Identification of tau
protein regions required for process formation in PC12 cells.
J Cell Sci
107:3403-3412 .
[Abstract]
-
Li Y,
Black MM
(1996)
Microtubule assembly and turnover in
growing axons.
J Neurosci
15:531-544.
-
Lim S-S,
Sammak PJ,
Borisy GG
(1989)
Progressive and
spatially differentiated stability of microtubules in developing
neuronal cells.
J Cell Biol
109:253-263 .
[Abstract/Free Full Text]
-
Mandell JW,
Banker GA
(1995)
The microtubule cytoskeleton and
the development of neuronal polarity.
Neurobiol Aging
16:229-238 .
[Web of Science][Medline]
-
Matus A
(1991)
Mictubule-associated proteins and neuronal
morphogenesis.
J Cell Sci [Suppl]
15:61-67 .
[Medline]
-
Miyata Y,
Hoshi M,
Nishida E,
Minami Y,
Sakai H
(1986)
Binding of microtubule-associated protein 2 and tau
to the intermediate filaments reassembled from neurofilament 70-fDa
subunit protein.
J Biol Chem
261:13026-13030 .
[Abstract/Free Full Text]
-
Moble WC,
Shenker A,
Shooter EM
(1976)
Characterization and
isolation of proteolytically modified nerve growth factor.
Biochemistry
15:5543-5551.
[Medline]
-
Noble M,
Lewis SA,
Cowan NJ
(1989)
The microtuble binding
domain of microtubule associated protein 1b contains a repeated
sequence motif unrelated to that of MAP2 and tau.
J Cell Biol
109:3367-3376 .
[Abstract/Free Full Text]
-
Peng I,
Binder LI,
Black MM
(1985)
Cultured neurons contain a
variety of microtubule-associated proteins.
Brain Res
361:200-211 .
[Web of Science][Medline]
-
Pryer NK,
Walker RA,
Skeen VP,
Bourns BD,
Soboeiro MF,
Salmon ED
(1992)
Brain microtubule-associated proteins modulate
microtubule dynamic instability in vitro. Real-time
observations using video microscopy.
J Cell Sci
103:965-976 .
[Abstract/Free Full Text]
-
Schliwa M,
van Blerkom JJ
(1981)
Structural interactions of
cytoskeletal components.
J Cell Biol
90:222-235 .
[Abstract/Free Full Text]
-
Schoenfeld TA,
Obar RA
(1994)
Diverse distribution and
function of fibrous microtubule-associated proteins in the nervous
system.
Int Rev Cytol
151:67-137 .
[Web of Science][Medline]
-
Seldon SC,
Pollard TD
(1983)
Phosphorylation of
microtubule-associated proteins regulates their interaction with
microfilaments.
J Biol Chem
258:7064-7071.
[Abstract/Free Full Text]
-
Takemura R,
Okabe S,
Umeyama T,
Kanai Y,
Cowan NJ,
Hirokawa N
(1992)
Increased microtubule stability and alpha-tubulin
acetylation in cells transfected with microtubule-associated proteins
MAP1B, MAP2 or tau.
J Cell Sci
103:953-964 .
[Abstract/Free Full Text]
-
Trinczek B,
Biernat J,
Baumann K,
Mandelkow E,
Mandelkow E
(1995)
Domains of tau protein, differential
phosphorylation, and dynamic instability of microtubules.
Mol Biol Cell
6:1887-1902 .
[Abstract]
-
Tucker RP
(1990)
The role of microtubule-associated proteins
in brain morphogenesis: a review.
Brain Res Rev
15:109-120.
-
Vallee RB
(1982)
A taxol-dependent procedure for the
isolation of microtubules and microtubule-associated proteins (MAPs).
J Cell Biol
92:435-442 .
[Abstract/Free Full Text]
-
Wiche G,
Oberkanins C,
Himmler A
(1991)
Molecular
structure and function of microtubule-associated proteins.
Int Rev Cytol
124:217-273 .
[Web of Science][Medline]
This article has been cited by other articles:

|
 |

|
 |
 
I. Tint, D. Jean, P. W. Baas, and M. M. Black
Doublecortin Associates with Microtubules Preferentially in Regions of the Axon Displaying Actin-Rich Protrusive Structures
J. Neurosci.,
September 2, 2009;
29(35):
10995 - 11010.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Dixit, J. L. Ross, Y. E. Goldman, and E. L. F. Holzbaur
Differential Regulation of Dynein and Kinesin Motor Proteins by Tau
Science,
February 22, 2008;
319(5866):
1086 - 1089.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. M. Sharma, J. M. Litersky, K. Bhaskar, and G. Lee
Tau impacts on growth-factor-stimulated actin remodeling
J. Cell Sci.,
March 1, 2007;
120(5):
748 - 757.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Vershinin, B. C. Carter, D. S. Razafsky, S. J. King, and S. P. Gross
Multiple-motor based transport and its regulation by Tau
PNAS,
January 2, 2007;
104(1):
87 - 92.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. E. King, H.-M. Kan, P. W. Baas, A. Erisir, C. G. Glabe, and G. S. Bloom
Tau-dependent microtubule disassembly initiated by prefibrillar {beta}-amyloid
J. Cell Biol.,
November 20, 2006;
175(4):
541 - 546.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-Z. Yu and M. M. Rasenick
Tau associates with actin in differentiating PC12 cells
FASEB J,
July 1, 2006;
20(9):
1452 - 1461.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. d. C. Alonso, B. Li, I. Grundke-Iqbal, and K. Iqbal
Polymerization of hyperphosphorylated tau into filaments eliminates its inhibitory activity
PNAS,
June 6, 2006;
103(23):
8864 - 8869.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Samsonov, J.-Z. Yu, M. Rasenick, and S. V. Popov
Tau interaction with microtubules in vivo
J. Cell Sci.,
December 1, 2004;
117(25):
6129 - 6141.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Errico, P. Claudiani, M. D'Addio, and E. I. Rugarli
Spastin interacts with the centrosomal protein NA14, and is enriched in the spindle pole, the midbody and the distal axon
Hum. Mol. Genet.,
September 15, 2004;
13(18):
2121 - 2132.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Trinczek, M. Brajenovic, A. Ebneth, and G. Drewes
MARK4 Is a Novel Microtubule-associated Proteins/Microtubule Affinity-regulating Kinase That Binds to the Cellular Microtubule Network and to Centrosomes
J. Biol. Chem.,
February 13, 2004;
279(7):
5915 - 5923.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Biernat, Y.-Z. Wu, T. Timm, Q. Zheng-Fischhofer, E. Mandelkow, L. Meijer, and E.-M. Mandelkow
Protein Kinase MARK/PAR-1 Is Required for Neurite Outgrowth and Establishment of Neuronal Polarity
Mol. Biol. Cell,
November 1, 2002;
13(11):
4013 - 4028.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Utton, J. Connell, A. A. Asuni, M. van Slegtenhorst, M. Hutton, R. de Silva, A. J. Lees, C. C. J. Miller, and B. H. Anderton
The Slow Axonal Transport of the Microtubule-Associated Protein Tau and the Transport Rates of Different Isoforms and Mutants in Cultured Neurons
J. Neurosci.,
August 1, 2002;
22(15):
6394 - 6400.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Kunda, G. Paglini, S. Quiroga, K. Kosik, and A. Caceres
Evidence for the Involvement of Tiam1 in Axon Formation
J. Neurosci.,
April 1, 2001;
21(7):
2361 - 2372.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Vogelsberg-Ragaglia, J. Bruce, C. Richter-Landsberg, B. Zhang, M. Hong, J. Q. Trojanowski, and V. M.-Y. Lee
Distinct FTDP-17 Missense Mutations in Tau Produce Tau Aggregates and Other Pathological Phenotypes in Transfected CHO Cells
Mol. Biol. Cell,
December 1, 2000;
11(12):
4093 - 4104.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
S. Roy, P. Coffee, G. Smith, R. K. H. Liem, S. T. Brady, and M. M. Black
Neurofilaments Are Transported Rapidly But Intermittently in Axons: Implications for Slow Axonal Transport
J. Neurosci.,
September 15, 2000;
20(18):
6849 - 6861.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Takei, J. Teng, A. Harada, and N. Hirokawa
Defects in Axonal Elongation and Neuronal Migration in Mice with Disrupted tau and map1b Genes
J. Cell Biol.,
September 4, 2000;
150(5):
989 - 1000.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Zmuda and R. Rivas
Actin disruption alters the localization of tau in the growth cones of cerebellar granule neurons
J. Cell Sci.,
January 8, 2000;
113(15):
2797 - 2809.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Hartigan and G. V. W. Johnson
Transient Increases in Intracellular Calcium Result in Prolonged Site-selective Increases in Tau Phosphorylation through a Glycogen Synthase Kinase 3beta -dependent Pathway
J. Biol. Chem.,
July 23, 1999;
274(30):
21395 - 21401.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Tint, T. Slaughter, I. Fischer, and M. M. Black
Acute Inactivation of Tau Has No Effect on Dynamics of Microtubules in Growing Axons of Cultured Sympathetic Neurons
J. Neurosci.,
November 1, 1998;
18(21):
8660 - 8673.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. A. Compagnone and S. H. Mellon
Dehydroepiandrosterone: A potential signalling molecule for neocortical organization during development
PNAS,
April 14, 1998;
95(8):
4678 - 4683.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G Lee, S. Newman, D. Gard, H Band, and G Panchamoorthy
Tau interacts with src-family non-receptor tyrosine kinases
J. Cell Sci.,
January 11, 1998;
111(21):
3167 - 3177.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Slaughter, J. Wang, and M. M. Black
Microtubule Transport from the Cell Body into the Axons of Growing Neurons
J. Neurosci.,
August 1, 1997;
17(15):
5807 - 5819.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U Preuss, J Biernat, E. Mandelkow, and E Mandelkow
The 'jaws' model of tau-microtubule interaction examined in CHO cells
J. Cell Sci.,
January 3, 1997;
110(6):
789 - 800.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Maas, J. Eidenmuller, and R. Brandt
Interaction of Tau with the Neural Membrane Cortex Is Regulated by Phosphorylation at Sites That Are Modified in Paired Helical Filaments
J. Biol. Chem.,
May 19, 2000;
275(21):
15733 - 15740.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|